Sign in

NCT05795166Completed

A Study to Understand the Distribution of Obesity Classes and Obesity Related Diseases in People With Obesity Across Countries in Czech Republic, Hungary and Poland

A Multicentre, Observational Study to Understand the Distribution of Obesity Classes and Obesity Related Comorbidities (ORCs) in People With Obesity Within a Real World Population in Czech Republic, Hungary and Poland

Source: ClinicalTrials.gov · Last updated 19 Sept 2024

Brief summary (registry, in English)

The study is intended to understand the distribution of different obesity classes and obesity related diseases (diseases that present along with obesity) in patients with body mass index (BMI) ≥ 30 kg/m\^2. Participants will be asked to give information about their health. They will continue their normal way of life and will not get any medication or additional medical test other than those prescribed to you by their doctor. Participation in the study will last for about 1 day.

Status (registry)
Completed
Study type
Observational
Enrollment
1241 (actual)
First submitted
21 Mar 2023
Start date
27 Apr 2023
Primary completion date
30 Nov 2023
Lead sponsor
Novo Nordisk A/S
Diseases
Obesity
NCT number
NCT05795166

What you commit to

  • Study type: Observational
  • Participants enrolled: 1241
  • From 27 Apr 2023 to the primary completion date, 30 Nov 2023
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous participation in this study. Participation is defined as having given informed consent in this study.

Other

  • Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation as judged by physician.

Who the study is looking for

  • Signed informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, age greater than or equal to 18 years at the time of inclusion/enrolment in the study.
  • BMI greater than or equal to 30 Kg/m\^2 as measured at the inclusion in the study

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.